Key Takeaways

Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in people who took 160 mg aspirin daily for three yearsAspirin has several effects that might counter cancer, researchers said

THURSDAY, Sept. 18, 2025 (HealthDay News) — Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found.

Daily aspirin reduced by 55% the risk of cancer recurrence in patients whose colorectal cancer is driven by a genetic mutation, researchers reported Sept. 17 in the New England Journal of Medicine .

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which is very positive,” lead researcher Anna Ma

See Full Page